COREBRIDGE FINANCIAL INC (CRBG)

US21871X1090 - Common Stock

29.66  +0.57 (+1.96%)

After market: 29.66 0 (0%)

Fundamental Rating

4

Taking everything into account, CRBG scores 4 out of 10 in our fundamental rating. CRBG was compared to 99 industry peers in the Financial Services industry. CRBG may be in some trouble as it scores bad on both profitability and health. CRBG may be a bit undervalued, certainly considering the very reasonable score on growth



3

1. Profitability

1.1 Basic Checks

CRBG had positive earnings in the past year.
CRBG had a positive operating cash flow in the past year.
In the past 5 years CRBG has always been profitable.
Each year in the past 5 years CRBG had a positive operating cash flow.

1.2 Ratios

CRBG has a Return On Assets of -0.31%. This is in the lower half of the industry: CRBG underperforms 77.78% of its industry peers.
The Return On Equity of CRBG (-9.19%) is worse than 78.79% of its industry peers.
Industry RankSector Rank
ROA -0.31%
ROE -9.19%
ROIC N/A
ROA(3y)1.44%
ROA(5y)0.9%
ROE(3y)41.14%
ROE(5y)25.06%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

CRBG's Profit Margin has improved in the last couple of years.
CRBG's Operating Margin has improved in the last couple of years.
The Profit Margin and Operating Margin and Gross Margin are not available for CRBG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3Y-15.86%
OM growth 5Y50.59%
PM growth 3Y10.16%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

2

2. Health

2.1 Basic Checks

CRBG does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CRBG has less shares outstanding
CRBG has a better debt/assets ratio than last year.

2.2 Solvency

CRBG has a debt to FCF ratio of 8.15. This is a slightly negative value and a sign of low solvency as CRBG would need 8.15 years to pay back of all of its debts.
With a Debt to FCF ratio value of 8.15, CRBG perfoms like the industry average, outperforming 53.54% of the companies in the same industry.
A Debt/Equity ratio of 0.88 indicates that CRBG is somewhat dependend on debt financing.
CRBG has a Debt to Equity ratio (0.88) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.88
Debt/FCF 8.15
Altman-Z N/A
ROIC/WACCN/A
WACC7.52%

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

4

3. Growth

3.1 Past

CRBG shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 18.02%, which is quite good.
Measured over the past years, CRBG shows a quite strong growth in Earnings Per Share. The EPS has been growing by 19.61% on average per year.
Looking at the last year, CRBG shows a very negative growth in Revenue. The Revenue has decreased by -21.40% in the last year.
Measured over the past years, CRBG shows a small growth in Revenue. The Revenue has been growing by 4.36% on average per year.
EPS 1Y (TTM)18.02%
EPS 3Y19.61%
EPS 5YN/A
EPS Q2Q%31.43%
Revenue 1Y (TTM)-21.4%
Revenue growth 3Y8.75%
Revenue growth 5Y4.36%
Sales Q2Q%-17.66%

3.2 Future

Based on estimates for the next years, CRBG will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.18% on average per year.
The Revenue is expected to grow by 4.51% on average over the next years.
EPS Next Y20.39%
EPS Next 2Y18.06%
EPS Next 3Y17.18%
EPS Next 5Y15.18%
Revenue Next Year-1.55%
Revenue Next 2Y3.78%
Revenue Next 3Y4.13%
Revenue Next 5Y4.51%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.

7

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 6.38, the valuation of CRBG can be described as very cheap.
89.90% of the companies in the same industry are more expensive than CRBG, based on the Price/Earnings ratio.
CRBG's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.73.
Based on the Price/Forward Earnings ratio of 5.19, the valuation of CRBG can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CRBG indicates a rather cheap valuation: CRBG is cheaper than 92.93% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.83. CRBG is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 6.38
Fwd PE 5.19

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, CRBG is valued a bit cheaper than 72.73% of the companies in the same industry.
Industry RankSector Rank
P/FCF 13.9
EV/EBITDA N/A

4.3 Compensation for Growth

CRBG's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CRBG's earnings are expected to grow with 17.18% in the coming years.
PEG (NY)0.31
PEG (5Y)N/A
EPS Next 2Y18.06%
EPS Next 3Y17.18%

3

5. Dividend

5.1 Amount

CRBG has a Yearly Dividend Yield of 3.16%. Purely for dividend investing, there may be better candidates out there.
CRBG's Dividend Yield is rather good when compared to the industry average which is at 3.76. CRBG pays more dividend than 82.83% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.34, CRBG pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.16%

5.2 History

CRBG has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1

5.3 Sustainability

CRBG has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-103.28%
EPS Next 2Y18.06%
EPS Next 3Y17.18%

COREBRIDGE FINANCIAL INC

NYSE:CRBG (12/20/2024, 8:04:00 PM)

After market: 29.66 0 (0%)

29.66

+0.57 (+1.96%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)11-04 2024-11-04/amc
Earnings (Next)02-13 2025-02-13/amc
Inst Owners101.26%
Inst Owner Change-4.11%
Ins Owners0.25%
Ins Owner Change-66.31%
Market Cap20.49B
Analysts77.14
Price Target37.66 (26.97%)
Short Float %0.98%
Short Ratio1.46
Dividend
Industry RankSector Rank
Dividend Yield 3.16%
Dividend Growth(5Y)N/A
DP-103.28%
Div Incr Years1
Div Non Decr Years1
Ex-Date12-17 2024-12-17 (0.23)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.56%
Min EPS beat(2)1.25%
Max EPS beat(2)15.87%
EPS beat(4)4
Avg EPS beat(4)5.96%
Min EPS beat(4)1.25%
Max EPS beat(4)15.87%
EPS beat(8)7
Avg EPS beat(8)8.55%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-25.28%
Min Revenue beat(2)-28.97%
Max Revenue beat(2)-21.6%
Revenue beat(4)2
Avg Revenue beat(4)-9.84%
Min Revenue beat(4)-28.97%
Max Revenue beat(4)5.71%
Revenue beat(8)5
Avg Revenue beat(8)-0.96%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)9.07%
PT rev (3m)9.46%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-6.03%
EPS NY rev (1m)1.83%
EPS NY rev (3m)2.26%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.11%
Revenue NY rev (1m)-2.46%
Revenue NY rev (3m)-4.75%
Valuation
Industry RankSector Rank
PE 6.38
Fwd PE 5.19
P/S 1.41
P/FCF 13.9
P/OCF 13.9
P/B 1.51
P/tB 1.51
EV/EBITDA N/A
EPS(TTM)4.65
EY15.68%
EPS(NY)5.71
Fwd EY19.27%
FCF(TTM)2.13
FCFY7.19%
OCF(TTM)2.13
OCFY7.19%
SpS21.11
BVpS19.7
TBVpS19.7
PEG (NY)0.31
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.31%
ROE -9.19%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM 10.11%
ROA(3y)1.44%
ROA(5y)0.9%
ROE(3y)41.14%
ROE(5y)25.06%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)1.74%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-15.86%
OM growth 5Y50.59%
PM growth 3Y10.16%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.04
Health
Industry RankSector Rank
Debt/Equity 0.88
Debt/FCF 8.15
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACC7.52%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)123.45%
Profit Quality(5y)1155.71%
High Growth Momentum
Growth
EPS 1Y (TTM)18.02%
EPS 3Y19.61%
EPS 5YN/A
EPS Q2Q%31.43%
EPS Next Y20.39%
EPS Next 2Y18.06%
EPS Next 3Y17.18%
EPS Next 5Y15.18%
Revenue 1Y (TTM)-21.4%
Revenue growth 3Y8.75%
Revenue growth 5Y4.36%
Sales Q2Q%-17.66%
Revenue Next Year-1.55%
Revenue Next 2Y3.78%
Revenue Next 3Y4.13%
Revenue Next 5Y4.51%
EBIT growth 1Y-157.65%
EBIT growth 3Y-8.5%
EBIT growth 5Y57.15%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-51.11%
FCF growth 3Y0.27%
FCF growth 5Y0.89%
OCF growth 1Y-51.11%
OCF growth 3Y0.27%
OCF growth 5Y0.89%